Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Amicus Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 290 | 5 | 286 | +1 |
| Shares | 305.4M | 3.90M | 312.7M | +11.2M (+3.7%) |
| Value | $2.88B | $36.7M | $2.55B | −$287.2M (−10.1%) |
5 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (41)
Institutions that held Amicus Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (40)
Institutions that held Amicus Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (5)
Institutions that held Amicus Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 3,807,420 | $35.9M |
| Mesirow Institutional Investment Management, Inc. | 89,382 | $842.0K |
| Virtus Fund Advisers, LLC | 3,108 | $29.3K |
| Global Retirement Partners, LLC | 46 | $433 |
| Cassady Schiller Wealth Management, LLC | 44 | $414 |